Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$31.23 - $40.91 $290,938 - $381,117
-9,316 Reduced 60.22%
6,154 $238,000
Q2 2023

Aug 14, 2023

SELL
$21.06 - $24.0 $89,378 - $101,856
-4,244 Reduced 21.53%
15,470 $332,000
Q1 2023

May 15, 2023

BUY
$23.0 - $29.88 $150,880 - $196,012
6,560 Added 49.87%
19,714 $472,000
Q4 2022

Feb 14, 2023

SELL
$16.14 - $23.55 $62,558 - $91,279
-3,876 Reduced 22.76%
13,154 $305,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $263,283 - $342,303
17,030 New
17,030 $273,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.